ENVOY MEDICAL INC (COCH) Stock Earnings & Estimates
USA - NASDAQ:COCH - US29415V1098 - Common Stock
0.7024 USD
-0.02 (-3.28%)
0.7262 USD
+0.02 (+3.39%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 316K | 225K -28.80% | 233.243K 3.66% | 306K 31.19% | ||
| EBITDA YoY % growth | N/A | -18.226M | -19.083M -4.70% | -22.644M -18.66% | N/A | |
| EBIT YoY % growth | -4.89M 5.96% | -18.359M -275.44% | -19.256M -4.89% | -21.592M -12.13% | -24.223M -12.19% | |
| Operating Margin | N/A | -5,809.81% | -8,558.22% | -9,257.23% | -7,916.11% | |
| EPS YoY % growth | N/A | N/A | -1.42 15.97% | -1.23 13.56% | -1.29 -4.71% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.32 14.54% | -0.33 27.93% | -0.31 -5.52% | -0.31 4.38% | -0.30 6.45% | -0.30 10.77% |
| Revenue Q2Q % growth | 71.4K 27.50% | 71.4K 70.00% | 51K 10.87% | 51K -34.62% | 51K -28.57% | 51K -28.57% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.219M -4.93% | -5.661M -25.13% | -5.865M -14.84% | -5.865M -15.68% | -5.865M -12.38% | -5.865M -3.60% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.32 -18.52% | -0.32 | 0.00 | -1.20% |
| Q1 2025 Q2Q % growth | -0.29 9.38% | -0.35 | 0.06 | 16.38% |
| Q4 2024 Q2Q % growth | -0.46 -17.95% | -0.33 | -0.13 | -39.48% |
| Q3 2024 Q2Q % growth | -0.37 | -0.28 | -0.09 | -32.71% |
| Q2 2024 Q2Q % growth | -0.27 | -0.26 | -0.01 | -4.83% |
| Q1 2024 Q2Q % growth | -0.32 | -0.27 | -0.05 | -20.66% |
| Q4 2023 Q2Q % growth | -0.39 | -0.20 | -0.19 | -96.08% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 78K 14.71% | 66.3K | 11.7K | 17.65% |
| Q1 2025 Q2Q % growth | 46K -22.03% | 68.003K | -22.003K | -32.36% |
| Q4 2024 Q2Q % growth | 42K -55.79% | 84.997K | -42.997K | -50.59% |
| Q3 2024 Q2Q % growth | 56K -30.00% | 84.997K | -28.997K | -34.12% |
| Q2 2024 Q2Q % growth | 68K | 84.15K | -16.15K | -19.19% |
| Q1 2024 Q2Q % growth | 59K | 102K | -43K | -42.16% |
| Q4 2023 Q2Q % growth | 95K | 89.25K | 5.75K | 6.44% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.09% | 2.11% | 4.31% | 5.5% |
| Revenue | 0% | 2.44% | 0% | -2.14% |